Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics
MR van Gerven, E Bozsaky, YAH Matser… - Cancer …, 2022 - Wiley Online Library
Neuroblastoma is the most common extracranial solid tumor in children. The chromatin
remodeler ATRX is frequently mutated in high‐risk patients with a poor prognosis. Although …
remodeler ATRX is frequently mutated in high‐risk patients with a poor prognosis. Although …
[HTML][HTML] Management of neuroblastoma in limited-resource settings
J Van Heerden, M Kruger - World journal of clinical oncology, 2020 - ncbi.nlm.nih.gov
BACKGROUND Neuroblastoma (NB) is a heterogeneous disease with variable outcomes
among countries. Little is known about NB in low-and middle-income countries (LMICs). AIM …
among countries. Little is known about NB in low-and middle-income countries (LMICs). AIM …
Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta
The majority of patients with high-risk neuroblastoma (HR-NB) in low-and middle-income
countries (LMIC) do not have access to autologous stem cell transplant (ASCT) and …
countries (LMIC) do not have access to autologous stem cell transplant (ASCT) and …
Neuroblastoma: The basis for cure in limited‐resource settings
J Van Heerden, M Kruger… - Pediatric Blood & …, 2021 - Wiley Online Library
Background Neuroblastoma (NB) contributes the most to the mortality of childhood
malignancies worldwide. The disease spectrum is heterogenous and the management …
malignancies worldwide. The disease spectrum is heterogenous and the management …
[PDF][PDF] Clinical Characteristics and Outcome of High Risk Neuroblastoma Treated at Sohag Cancer Center, Egypt
HA Sayed, MA Morsy, MG Nagib - secioj.journals.ekb.eg
Background objectives: Neuroblastoma is the most common extracranial solid tumor in
children. Nearly half of them are high risk at diagnosis according to the International …
children. Nearly half of them are high risk at diagnosis according to the International …
[HTML][HTML] The Impact of Pretransplant Disease Characteristics on the Outcome of Autologous Stem Cell Transplantation for Neuroblastoma with High-Risk Features: A …
A Elhemaly, M Hammad, MS Zaghloul… - Journal of Cancer …, 2019 - scirp.org
High-risk neuroblastoma still has poor survival outcome. Improvement of outcome is
attributed to the consolidation of chemotherapy by autologous bone marrow transplant …
attributed to the consolidation of chemotherapy by autologous bone marrow transplant …